Brussels, October 8, 2021: The European Brain Council (EBC), an organization that is at the forefront of advocacy for brain research in Europe and EBRAINS, an association that supports science in the field of brain research, including as coordinator of the EU-funded Human Brain Project, are together organizing the first European Brain Summit in [...]
The EBC Newsletter for June 2021 can be downloaded here.
Registration is now open for the two-day Brain Innovation Days event, to be held physically in Brussels, Belgium, on 12-13 October 2021. Under the overarching theme, United for Brain Innovation, the Brain Innovation Days will bring together, in-person*, key opinion leaders and stakeholders from the ever-growing brain innovation ecosystem to create synergies and showcase [...]
This week, the European Brain Council launched its 2020 Annual Report. In spite of a very challenging year, we are extremely proud that we were able to carry on our activities and continue to deliver upon the agenda and objectives that were defined for the organisation. COVID-19 naturally had a major impact on many areas [...]
The European Brain Council and the EBRAINS Research Infrastructure are pleased to invite you to the first European Brain Summit, a joint event that will take place on 12th October 2021 in Brussels from 13:30 to 18:00, in conjunction with the Brain Innovation Days and Human Brain Project Summit. This will be a unique [...]
Event Report: “Patient Safety and Informed Consent: The Importance of Good Off-label Use Practices” On 17 June 2021, the GOLUP consortium held a virtual event, led by the European Brain Council, to disseminate the Declaration on Good Off-Label Use Practices. The event was hosted by MEP Cyrus Engerer (S&D, Malta), who is a member of [...]
Alzheimer’s disease (AD) is a neurodegenerative disease that progresses in stages, beginning with a long silent phase before symptoms occur, and the underlying cause in 70% of people with dementia. Dementia, which is not a specific disease but an overall term that describes a group of symptoms, is characterized by a decline in memory, thinking, [...]
Kicked off in December 2020, a third stream of the Value of Treatment project on Transversal Topics is officially underway over a three-year period from 2021 to 2023. A case study on chronic pain has begun and soon a case study on sleep and wake disorders is to follow, potentially among others. The group [...]
On 8 June 2021, EBC hosted a virtual Synthesis Meeting for the Value of Treatment 2 case study working groups to present their preliminary findings. The Value of Treatment for Brain Disorders (VOT) is a health economics and outcomes research project coordinated by the European Brain Council (EBC). EBC conceptualized in 2015 the Value [...]
EBC is happy to recognise and support International Phenylketonuria (PKU) Day, which takes place annually on 28 June — the birthday of two stalwarts of PKU, Robert Guthrie (1916-1995) and Horst Bickel (1918-2000). The ongoing 2019-2021 Value of Treatment (VOT) project for Brain Disorders and its recent synthesis meeting on 8 June 2021 aimed to [...]
